Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

JNJ 98.47 0.00 (0.00%)
price chart
Johnson & Johnson to Remove Formaldehyde From Products
Johnson & Johnson, which makes a range of personal care products like baby shampoo, acne cream and antiwrinkle lotion, announced plans Wednesday to remove a host of potentially harmful chemicals, like formaldehyde, from its line of consumer products ...
Johnson & Johnson Removing 'Chemicals Of Concern" From Adult ...  Huffington Post
How Johnson & Johnson is cutting out toxics  GreenBiz.com
Johnson & Johnson Announces a Ban on Harmful Chemicals in Products
Johnson & Johnson made the landmark announcement this week that it would ban harmful chemicals from their products. The company has already made the pledge to remove toxic chemicals from its baby products by 2013.
The Real Lesson of Formaldehyde In Baby Shampoo  TIME
Time for companies to pledge to remove dangerous chemicals from products  Fox News
Trials for Alzheimer's Drug Halted After Poor Results
Johnson & Johnson and Pfizer announced on Monday that they were halting development of a closely watched Alzheimer's drug after two clinical trials failed to show that it was effective in patients with mild to moderate forms of the disease.
Pfizer, J&J scrap Alzheimer's studies as drug fails  Reuters
Medical hope for Alzheimer's drug dashed after treatment fails to ...  Daily Mail (blog)
Johnson & Johnson Still Hates Women With Heavier Than Normal Periods
Last year the internet was in an uproar because Johnson & Johnson discontinued OB Ultra Absorbency tampons. By internet, I mean women's sites, of course.
Johnson & Johnson unit recalls bone putty
The health regulator said certain lots of bone putty made by Johnson & Johnson unit Synthes were recalled as there was potential for the putty to catch fire if it came in contact with electrosurgical cautery systems during surgery.
Johnson & Johnson makes $50 million milestone payment to California-based ...
Janssen Biotech, part of Johnson & Johnson, will pay a $50 million milestone payment to Pharmacyclics, its collaborator on a new treatment for mantle cell lymphoma.
No More Tears: Johnson & Johnson Cleans Up Its Act and Removes Carcinogens
Prompted by growing concerns raised by the Campaign for Safe Cosmetics, Johnson & Johnson makers of Aveeno, Neutrogena, and Johnson's Baby Shampoo, announced today that it will be removing carcinogens and other toxic chemicals from its baby ...
Related articles »  
Johnson Johnson subsidiary to pay record amount to settle off-label marketing ...
Attorneys general in 37 states reached a record $181 million dollar settlement with Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson. They allege that Janssen improperly marketed the antipsychotic drugs Risperdal, Risperdal Consta, ...
Here Are The Allegations That Spurred J&J To Pay A $181 Million ...  Business Insider
J&J Will Pay $181 Million to Settle Risperdal Ad Claims  Bloomberg
Johnson & Johnson to pay $600k to settle suits over recalled hip implants
Johnson & Johnson, which faces about 8,000 lawsuits over hip implants it recalled in 2010, agreed to pay about $600,000 to resolve three cases in the first settlements of the litigation, people familiar with the accords said.
First DePuy Hip Replacement Lawsuits Settled for $200000 Each  DrugWatch.com
The Real Estate Whims of Libet Johnson: Heiress Looking to Sell the Vanderbilt ...
The problem with getting what you want is that sometimes, once you have it, you don't want it anymore. The Observer has learned that Libet Johnson is looking to offload the Vanderbilt Mansion, the stately neo-Georgian mansion at 16 East 69th Street ...